Recommended composition of influenza virus vaccines for use in the 2024 southern hemisphere influenza season
WHO convenes technical consultations in February and September each year to recommend viruses for inclusion in influenza vaccines for the northern hemisphere (NH) and southern hemisphere (SH) influenza seasons, respectively.
Vaccine Monitoring Platform research agenda
The Vaccine Monitoring Platform (VMP) is a collaboration between EMA and ECDC for the timely generation of independent real-world evidence (RWE) on the safety and effectiveness of vaccines in use in EU/EEA immunisation programs.
Scientific Papers
Article
News
Factors associated with delayed diagnosis of symptomatic adult COVID-19 cases presenting to primary care: a population-wide study during transition from Delta to Omicron BA.1 in Singapore
During pandemics, avoiding time delay in diagnosing infection is crucial.
Invitation to participate in the second public survey to inform the global research agenda on Public Health and Social Measures
WHO welcomes stakeholders from sectors such as health, education, transportation, agriculture, finance, social services to complete a public survey to identify priorities for a global research agenda on Public Health and Social Measures (PHSM).
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part
Benefits of ensitrelvir in Covid-19 and long Covid highlighted in two studies
The benefits of ensitrelvir use in patients with symptoms of long Covid and as a second-line treatment option for those hospitalised with Covid-19.
Is influenza B/Yamagata extinct and what public health implications could this have? An updated literature review and comprehensive assessment of global surveillance databases
Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan
CD8+ T cells provide robust antiviral immunity, but how epitope-specific T cells evolve across the human lifespan is unclear.
Joint EMA-ECDC press briefing on current state of respiratory diseases and treatments in the EU/EEA
As autumn season approaches the EMA and ECDC held a press briefing to provide latest information on respiratory diseases as well as vaccines and treatments available
|
9th Influenza Conference 2023
The Influenza B/Yamagata lineage appears to become extinct: implications for quadrivalent influenza vaccines?
SPI08 session from #ESWI2023
